Comparative efficacy of Bruton tyrosine kinase inhibitors in high-risk relapsed/refractory CLL: a network meta-analysis

Shadman, M., Brown, J. R., Mohseninejad, L., Yang, K., Burnett, H., Neupane, B., Williams, R., Lamanna, N., O’Brien, S. M., Tedeschi, A., & Tam, C. S. (2025). Comparative efficacy of Bruton tyrosine kinase inhibitors in high-risk relapsed/refractory CLL: a network meta-analysis. Blood Advances. https://doi.org/10.1182/bloodadvances.2024014523

Authors:

Mazyar Shadman

Jennifer R Brown

Leyla Mohseninejad

Keri Yang

Heather Burnett

Binod Neupane

Rhys Williams

Nicole Lamanna

Susan M O'Brien

Alessandra Tedeschi

Constantine S Tam